Search Clinical Trials
Parent Therapeutic Areas: Gastroenterology

Ulcerative Colitis

Alabama

Birmingham : University of Alabama at Birmingham

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Birmingham : Children's Hospital of Alabama

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Birmingham : University of Alabama Birmingham

Moderate to Severe Ulcerative Colitis

Huntsville : Alabama Digestive Disorders Center, P.C.

Moderate to Severe Ulcerative Colitis

Montgomery : Alabama Liver & Digestive Specialists

Moderate to Severe Ulcerative Colitis

Arizona

Phoenix : Phoenix Children's Hospital

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Scottsdale : Colon and Digestive Health Specialist

Moderate to Severe Ulcerative Colitis

Tucson : Arizona Clinical Research Center, Inc.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Tucson : Desert Sun Gastroenterology

Moderate to Severe Ulcerative Colitis

Arkansas

Jonesborough : Clopton Clinic of Gastroenterology

Moderate to Severe Ulcerative Colitis

Lowell : Pharm Eval Inc.

Moderate to Severe Ulcerative Colitis

California

Buena Park : Unified Research

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Fresno : UCSF Fresno

Moderate to Severe Ulcerative Colitis

Los Angeles : Cedars Sinai Medical Center

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Orange : UCI Medical Center, Department of Medicine, Division of Gastroenterology

Moderate to Severe Ulcerative Colitis

Roseville : Capitol Gastroenterology Consultants Medical Group, Inc.

Moderate to Severe Ulcerative Colitis

San Carlos : Digestive Care Medical Center

Moderate to Severe Ulcerative Colitis

Santa Monica : Marc D. Wishingrad, MD, Inc.

Moderate to Severe Ulcerative Colitis

Colorado

Aurora : The Children's Hospital

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Golden : Rocky Mountain Clinical Research

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Lafayette : Clinical Research of the Rockies

Moderate to Severe Ulcerative Colitis

Littleton : Rocky Mountain Clinical Research, LLC

Moderate to Severe Ulcerative Colitis

Thornton : Rocky Mountain Gastroenterology Associates, LLC

Moderate to Severe Ulcerative Colitis

Connecticut

Hamden : Medical Research Center of Connecticut

Moderate to Severe Ulcerative Colitis

Hartford : Connecticut Children's Medical Center

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Hartford : Connecticut Gastroenterology & Medical Associates

Moderate to Severe Ulcerative Colitis

Florida

Cape Coral : Associates in Digestive Health

Moderate to Severe Ulcerative Colitis

Gainesville : University of Florida

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Hollywood : Gastroenterology Consultants, P.A.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Hollywood : Southern Clinical Research Consultants

Moderate to Severe Ulcerative Colitis

Jacksonville : Borland-Groover Clinic

Moderate to Severe Ulcerative Colitis

Miami : A + Research, Inc.

Moderate to Severe Ulcerative Colitis

New Port Richey : Advanced Research Institute

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

North Miami Beach : Venture Research Institute

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Orlando : Nemour's Children's Clinic

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Ormond Beach : Peninsula Research Inc.

Do you have Ulcerative Colitis?

Port Orange : Accord Clinical Research, LLC

Ulcerative Colitis

West Palm Beach : Palm Beach Research Center

Ulcerative Colitis? Research Study

Winter Park : Shafran Gastroenterology Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Winter Park : Shafran Gastroenterology Center

Moderate to Severe Ulcerative Colitis

Georgia

Atlanta : Atlanta Gastroenterology Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Atlanta : Children's Center for Digestive Health Care

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Atlanta : Metro Atlanta Gastroenterology

Moderate to Severe Ulcerative Colitis

Atlanta : Atlanta Gastroenterology Associates

Moderate to Severe Ulcerative Colitis

Savannah : St. Joseph's/Candler Health System

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Illinois

Arlington Heights : Northwest Gastroenterologists S.C.

Moderate to Severe Ulcerative Colitis

Chicago : Rush University Medical Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Chicago : The University of Chicago Hospitals

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Chicago : Rush University Medical Center - Treatment Research Center

Dysbiosis in inflammatory bowel disease.

Chicago : Rush University Medical Center - Treatment Research Center

Mind/Body Medicine and IBD Flare-up

Chicago : University of Chicago Medical Center

Moderate to Severe Ulcerative Colitis

Chicago : Rush University Medical Center

Moderate to Severe Ulcerative Colitis

Peoria : Illinois Gastroenterology Institute

Moderate to Severe Ulcerative Colitis

Indiana

Anderson : Saint Johns Research Institute

Moderate to Severe Ulcerative Colitis

Indianapolis : Riley Hospital for Children

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Iowa

Clive : Iowa Digestive Disease Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Davenport : Gastrointestinal Clinic of Quad Cities

Moderate to Severe Ulcerative Colitis

Kansas

Topeka : Cotton-O'Neil Clinical Research Center, Digestive Health

Moderate to Severe Ulcerative Colitis

Kentucky

Lexington : University of Kentucky Medical Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Louisiana

Baton Rouge : Gastroenterology Associates, LLC

Moderate to Severe Ulcerative Colitis

Monroe : Bhandari, Baj Raj

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

New Orleans : Ochsner Clinic Foundation

Moderate to Severe Ulcerative Colitis

Shreveport : Louisiana Research Center, LLC

Moderate to Severe Ulcerative Colitis

Maryland

Chevy Chase : Chevy Chase Clinical Research/Metropolitan Gastroenterology Group

Do you suffer from Ulcerative Colitis?

Chevy Chase : Metropolitan Gastroenterology Group, PC, Chevy Chase Clinical Research

Moderate to Severe Ulcerative Colitis

Hagerstown : Washington County Hospital

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Hagerstown : Center for Clinical Research at Washington County Hospital

Moderate to Severe Ulcerative Colitis

Laurel : Maryland Digestive Disease Research, LLC

Moderate to Severe Ulcerative Colitis

Massachusetts

Boston : Mass General Hospital for Children

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Boston : Massachusetts General Hospital New!

Investigational Drug Vedolizumab (MLN0002) for Adults with Moderate to Severe Ulcerative Colitis

Boston : Partners Healthcare System

Moderate to Severe Ulcerative Colitis

Braintree : Coastal Research Associates, Inc., Highland Medical Center

Moderate to Severe Ulcerative Colitis

Southbridge : John G. Stagias, MD

Moderate to Severe Ulcerative Colitis

Michigan

Chesterfield : Clinical Research Institute of Michigan, LLC

Moderate to Severe Ulcerative Colitis

Novi : Henry Ford Medical Center Columbus

Moderate to Severe Ulcerative Colitis

Minnesota

Plymouth : Minnesota Gastroenterologists

Moderate to Severe Ulcerative Colitis

Rochester : Mayo Clinic Rochester

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Mississippi

Jackson : Gastrointestinal Associates, P.A.

Moderate to Severe Ulcerative Colitis

Tupelo : Digestive Health Specialists

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

New Hampshire

Lebanon : Dartmouth-Hitchcock Medical Center

Moderate to Severe Ulcerative Colitis

New Jersey

Cedar Knolls : Gastroenterology Research Associates, LLC

Just hanging in there with your Ulcerative Colitis?

Egg Harbor Township : Atlantic Gastroenterology Associates

How do UC Life?

Egg Harbor Township : AGA Clinical Research Associates, LLC

Moderate to Severe Ulcerative Colitis

Egg Harbor Twp. : Atlantic Gastroenterology Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Ocean : Shore Health Group

Moderate to Severe Ulcerative Colitis

New York

Brooklyn : Preferred Health Partners

Moderate to Severe Ulcerative Colitis

Great Neck : Long Island Clinical Research Associates

Moderate to Severe Ulcerative Colitis

New Hyde Park : Biomedical Research Alliance of New York

Children and Adolescents with Mildly-to-Moderately Active Ulcerative Colitis

New Hyde Park : North Shore- LIJ Health System

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

New York : Research Associates of New York

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

New York : Mount Sinai Medical Center

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]

New York : Mount Sinai Medical Center

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]

New York : Mount Sinai Medical Center

A Phase I, Blinded, Multicenter, Dose-escalation, Placebo-controlled, Single-dose Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]

New York : Mount Sinai Medical Center

A Phase I, Multicenter, Dose-escalation, Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]

New York : Research Associates of New York

Active Ulcerative Proctitis

Rochester : Rochester Institute for Digestive Diseases & Sciences, Inc

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Rochester : University of Rochester Medical Center

Moderate to Severe Ulcerative Colitis

Rockville Center : Larry Good MD

Moderate to Severe Ulcerative Colitis

Stony Brook : Stony Brook Medical Center

Moderate to Severe Ulcerative Colitis

North Carolina

Asheville : Asheville Gastroenterology Associates, P.A.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Boone : Medispect, LLC

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Charlotte : Carolina Digestive Health Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Charlotte : Charlotte Gastroenterology and Hepatology, PLLC

Moderate to Severe Ulcerative Colitis

Durham : Duke University Medical Center

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Greenville : Carolina Research

Moderate to Severe Ulcerative Colitis

Huntersville : Carolinas Research Associates

Efficacy and safety of new oral budesonide-MMX™ (CB-01-02) 6 mg and 9 mg extended release tablet formulations in patients with mild or moderate, active ulcerative colitis. A multicenter, randomized, double-blind, double dummy comparative study versus placebo, with an additional reference arm evaluating Asacol® 2400 mg.

Huntersville : Carolinas Research Associates

M06-826 - A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderately to Severely Active Ulcerative Colitis.

New Bern : Southern Gastroenterology Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Raleigh : Wake Research Associates, LLC

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Raleigh : Multi-Specialty Research Associates of NC

Do you have ulcerative colitis in remission?

Rutherford College : Burke Research Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Wilmington : Hanover Medical Specialists, P.A.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Winston Salem : Wake Forest University Baptist Medical Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

North Dakota

Fargo : Odyssey Research

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Fargo : Odyssey Research Services

An Ulcerative Colitis Research Study

Ohio

Cincinnati : Gastroenterology Research Consultants of Greater Cincinnati

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Cleveland : Case Medical Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Cleveland : Cleveland Clinic

Moderate to Severe Ulcerative Colitis

Columbus : Remington-Davis, Inc.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Columbus : Columbus Children's Hospital, PCTI

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Columbus : Remington-Davis, Inc.

Moderate to Severe Ulcerative Colitis

Dayton : Wright State University School of Medicine

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Dayton : Dayton Science Institute

Moderate to Severe Ulcerative Colitis

Dayton : Gastrointestinal and Liver Diseases Consultants

Moderate to Severe Ulcerative Colitis

Mentor : Great Lakes Gastroenterology

Moderate to Severe Ulcerative Colitis

Westlake : North Shore Gastroenterology

Moderate to Severe Ulcerative Colitis

Oklahoma

Norman : Central Sooner Research

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Oregon

Portland : Portland Clinic

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Portland : Oregon Health & Science University

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Portland : West Hills Gastroenterology Research

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Pennsylvania

Philadelphia : The Children's Hospital of Philadelphia

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Philadelphia : Thomas Jefferson University

Moderate to Severe Ulcerative Colitis

Sayre : Guthrie Foundation for Education and Research

Moderate to Severe Ulcerative Colitis

Rhode Island

Providence : Rhode Island Hospital

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

South Carolina

Charleston : Charleston Gastroenterology Center

Moderate to Severe Ulcerative Colitis

Columbia : Columbia Gastroenterology Associates

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Tennessee

Franklin : Franklin Gastroenterology, PLLC

Moderate to Severe Ulcerative Colitis

Germantown : Memphis Gastrenterology Group (SCRI)

Moderate to Severe Ulcerative Colitis

Nashville : Nashville Medical Research

Moderate to Severe Ulcerative Colitis

Union City : Advanced Gastroenterology

Moderate to Severe Ulcerative Colitis

Texas

Denton : Pharmaseek, LLC

Moderate to Severe Ulcerative Colitis

Houston : Ertan, Atilla (private practice)

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Houston : DynaMed Clinical Research

Ulcerative Colitis - Houston, TX

Plano : Digestive Health Associates of Texas

Moderate to Severe Ulcerative Colitis

San Antonio : Clinical Trials of Texas, Inc.

(CB-01-02/01)Randomized Placebo Controlled Trial of Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg in Patients With Ulcerative Colitis

San Antonio : Gastroenterology Clinic of San Antonio, PA

Moderate to Severe Ulcerative Colitis

Utah

South Ogden : Advanced Research Institute

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Virginia

Chesapeake : Gastroenterology Associates of Tidewater

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Chesapeake : Gastroenterology Associates of Tidewater

A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.

Roanoke : Summit Medical Research Ltd

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Washington

Seattle : University of Washington Medical Center

Moderate to Severe Ulcerative Colitis

Spokane : Spokane Digestive Disease Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Tacoma : Digestive Health Specialists

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Wisconsin

Milwaukee : Advanced Healthcare, SC-Clinical Research Center

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Milwaukee : Medical College of Wisconsin

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Milwaukee : Medical College of Wisconsin

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Canada

Edmonton, AB : Aberthart Centre #1

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Halifax, NS : IWK Health Centre

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Hamilton, ON : McMaster Children's Hospital

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Montreal, Quebec : Jewish General Hospital

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Montreal, Quebec : CHUM Hopital Saint-Luc

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Ottawa, Ontario : Hassard, Philip MD

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Saskatoon, SK : Edwin Larkai Medical Professional Corporation

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Toronto, ON : The Hospital for Sick Children

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Toronto, Ontario : Toronto Digestive Disease Associates, Inc.

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Toronto, Ontario : Sunnybrook Health Sciences Centre

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

Vancouver, BC : B.C. Children's Hospital

Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).

Winnipeg, MB : Health Sciences Centre

A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis